C12Y 304/21045
Complement factor i
Official title: Complement factor I (3.4.21.45)
C12Y304/21045 (Complement factor i) appears on 2 US grants and 9 published applications in this corpus.
Search patents in C12Y- Granted patents
- 2
- Published applications
- 9
- Assignees
- 6
- Inventors
- 31
- Latest grant
- 8 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2020 | 0 | 2 |
| 2021 | 0 | 1 |
| 2022 | 0 | 1 |
| 2023 | 0 | 2 |
| 2024 | 1 | 1 |
| 2025 | 0 | 2 |
| 2026 | 1 | 0 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Complement factor i-related compositions and methods1 May 2025US 2025/0136965 A1Vertex Pharmaceuticals Incorporated
- Complement factor-i formulations9 Jan 2025US 2025/0009855 A1Vertex Pharmaceuticals Incorporated
- C3b inactivating polypeptide10 Oct 2024US 2024/0336675 A1Complement Therapeutics Limited
- Methods of producing recombinant complement proteins, vectors and therapeutic uses thereof6 Jul 2023US 2023/0212635 A1Gyroscope Therapeutics Limited
- Complement factor i-related compositions and methods9 Feb 2023US 2023/0038638 A1Vertex Pharmaceuticals Incorporated
Most cited
By later US patents
No patent in this class has been cited by a later US patent yet.